Chapter 25 : Pathogenesis of

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Pathogenesis of , Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap25-1.gif /docserver/preview/fulltext/10.1128/9781555815776/9781555813680_Chap25-2.gif


can be detected in small numbers in hosts with intact immune systems, although the precise kinetics of this host-pathogen relationship are only now being systematically studied. Recent studies have detected DNA in neonatal human and rat populations, but an assessment of potential reservoirs in the general population is only in its infancy. The sheer number of -seropositive immunocompetent individuals argues against the fulminant pneumonia (PCP)-infected host as the primary source of infection, since these patients are rare (in relation to the general public) and are often hospitalized or have limited access to the general population. Studies now being conducted with human populations, both immunosuppressed and non-immunsuppressed, point to certain reservoirs of infection in the general population, including patients with underlying disease states besides human immunodeficiency virus infection (HIV) or overt immunosuppression, neonates, and possibly pregnant women. This is an active and concerted area of research, and basic epidemiological principles for infection should emerge within the next few years. Immunoblotting studies identified the major immunoglobulin G-reactive antigens of from humans and animal models to be present at two regions with distinct molecular masses. life cycle stages form tightly bound aggregates within the lung alveoli, presumably mediated by major surface glycoproteins (MSGs)-MSG interactions. A lack of clonal populations and of the ability to manipulate the genetics of has prevented the demonstration of specific virulence factors.

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1.
Figure 1.

Morphological forms of Transmission electron micrographs of developmental forms of are shown. (A) Trophic forms (T) in the alveolar lumen; most of these are attached to type I pneumocytes (arrow). The large cell at the top of the photograph is a macrophage (not fully shown). (B) A cyst/ascus (C) containing three ascospores (S). The single arrow indicates the double membrane and expanded periplasmic space; the double arrows indicate an area of increased periplasmic space often seen in this stage. A large trophic form is visible at the bottom right. (C) A cluster of trophic forms (T) adhered to one another and anchored by attachment to the type I pneumocytes extend into the alveolar lumen. The trophic form (T*) may be undergoing binary fission. Magnification, ×10,000. Courtesy of M. T. C and Susan G. Langreth, Uniformed Services University of the Health Sciences, Bethesda, Md.

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2.
Figure 2.

Proposed life cycle of in the alveolar lumen (pictured in left panel as a rectangle). (A) Asexual binary fission. A trophic form replicates its nuclear content, separates by binary fission, and produces two genetically identical progeny. (B) Sexual replication. The two proposed mating types of are represented by the light gray and dark gray cytoplasms. The two mating types fuse and undergo karyogamy to produce a diploid zygote or “pre-cyst.” Meiosis proceeds with a reduction division followed by a mitotic replication, resulting in four nuclei. An additional mitotic replication of the haploid nuclei results in eight nuclei, which are then sequestered into eight individual spores or daughter forms. It is assumed that the spores are released from the mature cyst (ascus) and become new vegetative trophic forms. Figure created with SmartDraw v.7.0.

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3.
Figure 3.

Proposed mechanism of MSG expression. Genes encoding MSG are arranged in arrays in a subtelomeric location on the ends of each chromosome. The arrays also contain genes encoding the MSG-related protein (MSR) and protease (PRT). One MSG gene present at an expression site (UCS locus) on chromosome 9 is actively transcribed. MSG gene translocation to the expression site may involve sequence-specific recombination, homologous crossover, or gene conversion. All transcribed MSG mRNAs contain the UCS sequence and result in the production of a preproprotein, which is postulated to be processed through the endoplasmic reticulum (ER). Cleavage of a signal peptide would result in a proprotein which undergoes posttranslational modification including attachment of a glycosyl phosphatidylinositol (GPI) anchor. PRT1 proteases may be involved in the cleavage of the UCS sequence from the proMSG protein to result in the surface expression of the mature MSG protein. (Adapted from reference .)

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Achari, A.,, D. O. Somers,, J. N. Champness,, P. K. Bryant,, J. Rosemond, and, D. K. Stammers. 1997. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat. Struct. Biol. 4: 490497.
2. Agostini, C.,, F. Adami,, L. W. Poulter,, D. Israel-Biet,, M. Freitas e Costa,, A. Cipriani,, R. Sancetta,, M. C. Lipman,, K. Juvin,, A. D. Teles-Araujo,, P. Cadrobbi,, G. Masarotto, and, G. Semenzato. 1997. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection. Am. J. Respir. Crit. Care Med. 156: 15011507.
3. Ambrose, H. E.,, S. P. Keely,, E. M. Aliouat,, E. Dei-Cas,, A. E. Wakefield,, R. F. Miller, and, J. R. Stringer. 2004. Expression and complexity of the PRT1 multigene family of Pneumocystis carinii. Microbiology 150: 293300.
4. Atochina, E. N.,, J. M. Beck,, A. M. Preston,, A. Haczku,, Y. Tomer,, S. T. Scanlon,, T. Fusaro,, J. Casey,, S. Hawgood,, A. J. Gow, and, M. F. Beers. 2004. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect. Immun. 72: 60026011.
5. Atochina, E. N.,, A. J. Gow,, J. M. Beck,, A. Haczku,, A. Inch,, H. Kadire,, Y. Tomer,, C. Davis,, A. M. Preston,, F. Poulain,, S. Hawgood, and, M. F. Beers. 2004. Delayed clearance of Pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J. Infect. Dis. 189: 15281539.
6. Beard, C. B.,, J. L. Carter,, S. P. Keely,, L. Huang,, N. J. Pieniazek,, I. N. Moura,, J. M. Roberts,, A. W. Hightower,, M. S. Bens,, A. R. Freeman,, S. Lee,, J. R. Stringer,, J. S. Duchin,, C. del Rio,, D. Rimland,, R. P. Baughman,, D. A. Levy,, V. J. Dietz,, P. Simon, and, T. R. Navin. 2000. Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. Emerg. Infect. Dis. 6: 265272.
7. Beard, C. B.,, P. Roux,, G. Nevez,, P. M. Hauser,, J. A. Kovacs,, T. R. Unnasch, and, B. Lundgren. 2004. Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. Emerg. Infect. Dis. 10: 17291735.
8. Beck, J. M., and, A. G. Harmsen. 1998. Lymphocytes in host defense against Pneumocystis carinii. Semin. Respir. Infect. 13: 330338.
9. Beck, J. M.,, R. L. Newbury,, B. E. Palmer,, M. L. Warnock,, P. K. Byrd, and, H. B. Kaltreider. 1996. Role of CD8 + lymphocytes in host defense against Pneumocystis carinii in mice. J. Lab. Clin. Med. 128: 477487.
10. Beck, J. M.,, A. M. Preston, and, M. R. Gyetko. 1999. Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice. Infect. Immun. 67: 879884.
11. Beers, M. F.,, E. N. Atochina,, A. M. Preston, and, J. M. Beck. 1999. Inhibition of lung surfactant protein B expression during Pneumocystis carinii pneumonia in mice. J. Lab. Clin. Med. 133: 423433.
12. Bonagura, V. R.,, S. Cunningham-Rundles,, B. L. Edwards,, N. T. Ilowite,, J. F. Wedgwood, and, D. J. Valacer. 1989. Common variable hypogammaglobulinemia, recurrent Pneumocystis carinii pneumonia on intravenous gamma-globulin therapy, and natural killer deficiency. Clin. Immunol. Immunopathol. 51: 216231.
13. Calderon, E.,, C. de la Horra,, F. J. Medrano,, A. Lopez-Suarez,, M. A. Montes-Cano,, N. Respaldiza,, J. Elvira-Gonzalez,, J. Martin-Juan,, A. Bascunana, and, J. M. Varela. 2004. Pneumocystis jirovecii isolates with dihydropteroate synthase mutations in patients with chronic bronchitis. Eur. J. Clin. Microbiol. Infect. Dis. 23: 545549.
14. Centers for Disease Control and Prevention. 1999. USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA). Infect. Dis. Obstet. Gynecol. 8: 574.
15. Chabe, M.,, S. L. Vargas,, I. Eyzaguirre,, E. M. Aliouat,, A. Follet-Dumoulin,, C. Creusy,, L. Fleurisse,, C. Recourt,, D. Camus,, E. Dei-Cas, and, I. Durand-Joly. 2004. Molecular typing of Pneumocystis jirovecii found in formalin-fixed paraffin-embedded lung tissue sections from sudden infant death victims. Microbiology 150: 11671172.
16. Chagas, C. 1909. Nova tripanozomiaze humana. Mem. Inst. Oswaldo Cruz 1: 159218.
17. Chen, W.,, E. A. Havell,, F. Gigliotti, and, A. G. Harmsen. 1993. Interleukin-6 production in a murine model of Pneumocystis carinii pneumonia: relation to resistance and inflammatory response. Infect. Immun. 61: 97102.
18. Cushion, M. T.,, S. Keely, and, J. R. Stringer. 2004. Molecular and phenotypic description of Pneumocystis wakefieldiae sp. nov., a new species in rats. Mycologia 96: 429438.
19. Cushion, M. T. 2004. Pneumocystis: unraveling the cloak of obscurity. Trends Microbiol. 12: 243249.
20. D’Souza, N. B.,, J. F. Mandujano,, S. Nelson,, W. R. Summer, and, J. E. Shellito. 1995. Alcohol ingestion impairs host defenses predisposing otherwise healthy mice to Pneumocystis carinii infection. Alcohol Clin. Exp. Res. 19: 12191225.
21. Daly, K. R.,, C. J. Fichtenbaum,, R. Tanaka,, M. J. Linke,, R. O’Bert,, T. D. Thullen,, M. S. Hui,, A. G. Smulian, and, P. D. Walzer. 2002. Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jirovecii differ in human immunodeficiency virus-infected and uninfected persons. J. Infect. Dis. 186: 644651.
22. Delanoë, P., and, M. Delanoë. 1912. Sur les rapports des kystes des Carinii des poumon des rats avec le Trypanosoma lewisii. C. R. Acad. Sci. (Paris) 155: 658660.
23. Downing, J. F.,, D. L. Kachel,, R. Pasula, and, W. J. Martin. 1999. Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine-and tumor necrosis factor-dependent mechanisms. Infect. Immun. 67: 13471352.
24. Edman, J. C.,, J. A. Kovacs,, H. Masur,, D. V. Santi,, H. J. Elwood, and, M. L. Sogin. 1988. Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. Nature 334: 519522.
25. Eriksson, O. E. 1994. Pneumocystis carinii, a parasite in lungs of mammals, referred to as a new family and order ( Pneumocystidaceae, Pneumocystidales, Ascomycota). Syst. Ascomycetum 13: 165180.
26. Eriksson, O. E., and, K. Winka. 1997. Families and higher taxa of Ascomycota. Myconet 1: 1724.
27. Fisk, D. T.,, S. Meshnick, and, P. H. Kazanjian. 2003. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin. Infect. Dis. 36: 7078.
28. Fox, D., and, A. G. Smulian. 2001. Plasminogen-binding activity of enolase in the opportunistic pathogen Pneumocystis carinii. Med. Mycol. 39: 495507.
29. Frenkel, J. K. 1999. Pneumocystis pneumonia, an immunodeficiency-dependent disease (IDD): a critical historical overview. J. Eukaryot. Microbiol. 46: 89S92S.
30. Garvy, B. A., and, A. G. Harmsen. 1996. Susceptibility to Pneumocystis carinii infection: host responses of neonatal mice from immune or naive mothers and of immune or naive adults. Infect. Immun. 64: 39873992.
31. Gigliotti, F., and, W. T. Hughes. 1988. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J. Clin. Investig. 81: 16661668.
32. Gigliotti, F.,, J. A. Wiley, and, A. G. Harmsen. 1998. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect. Immun. 66: 31793182.
33. Giuntoli, D.,, S. L. Stringer, and, J. R. Stringer. 1994. Extraordinarily low number of ribosomal RNA genes in P. carinii., J. Eukaryot. Microbiol. 41: 88S.
34. Grewal, I. S.,, J. Xu, and, R. A. Flavell. 1995. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617620.
35. Hahn, P. Y., and, A. H. Limper. 2003. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Semin. Respir. Infect. 18: 4047.
36. Hanano, R., and, S. H. Kaufmann. 1999. Pneumocystis carinii pneumonia in mutant mice deficient in both TCRalphabeta and TCRgammadelta cells: cytokine and antibody responses. J. Infect. Dis. 179: 455459.
37. Hanano, R.,, K. Reifenberg, and, S. H. Kaufmann. 1998. Activated pulmonary macrophages are insufficient for resistance against Pneumocystis carinii. Infect. Immun. 66: 305314.
38. Harmsen, A. G.,, W. Chen, and, F. Gigliotti. 1995. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect. Immun. 63: 23912395.
39. Harmsen, A. G., and, M. Stankiewicz. 1990. Requirement for CD4 + cells in resistance to Pneumocystis carinii pneumonia in mice. J. Exp. Med. 172: 937945.
40. Helweg-Larsen, J.,, J. S. Jensen,, B. Dohn,, T. L. Benfield, and, B. Lundgren. 2002. Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia—a case-control study. BMC. Infect. Dis. 2: 28.
41. Herting, E.,, O. Moller,, J. H. Schiffmann, and, B. Robertson. 2002. Surfactant improves oxygenation in infants and children with pneumonia and acute respiratory distress syndrome. Acta Paediatr. 91: 11741178.
42. Hori, S.,, T. L. Carvalho, and, J. Demengeot. 2002. CD25 + CD4 + regulatory T cells suppress CD4 + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32: 12821291.
43. Huang, L.,, K. Crothers,, C. Atzori,, T. Benfield,, R. Miller,, M. Rabodonirina, and, J. Helweg-Larsen. 2004. Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance. Emerg. Infect. Dis. 10: 17211728.
44. Hughes, W. T. 1982. Natural mode of acquisition for de novo infection with Pneumocystis carinii. J. Infect. Dis. 145: 842848.
45. Hughes, W. T. 1989. Animal models for Pneumocystis carinii pneumonia. J. Protozool. 36: 4145.
46. Hughes, W. T. 2004. Pneumocystis Pneumonitis in non-HIV-infected Patients: Update, p. 407434. In M. T. Cushion and, P. D. Walzer (ed.), Pneumocystis Pneumonia. Marcel Dekker, Inc., New York, N.Y.
47. Icenhour, C. R., and, M. T. Cushion. 2001. Putative transmissive form of Pneumocystis carinii f. sp. carinii. J. Eukaryot. Microbiol. Suppl.: 139S140S.
48. Icenhour, C. R.,, S. L. Rebholz,, M. S. Collins, and, M. T. Cushion. 2001. Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J. Clin. Microbiol. 39: 34373441.
49. Icenhour, C. R.,, S. L. Rebholz,, M. S. Collins, and, M. T. Cushion. 2002. Early acquisition of Pneumocystis carinii in neonatal rats as evidenced by PCR and oral swabs. Eukaryot. Cell 1: 414419.
50. Iliades, P.,, S. R. Meshnick, and, I. G. Macreadie. 2004. Dihydropteroate synthase mutations in Pneumocystis jirovecii can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob. Agents Chemother. 48: 26172623.
51. International Association for Plant Taxonomy. 2000. International Code of Botanical Nomenclature. Lubrecht & Cramer Ltd, Konigstein, Germany.
52. Justice, A. C.,, C. S. Landefeld,, S. M. Asch,, A. L. Gifford,, C. C. Whalen, and, K. E. Covinsky. 2001. Justification for a new cohort study of people aging with and without HIV infection. J. Clin. Epidemiol. 54 (suppl. 1): S3S8.
53. Kazanjian, P.,, W. Armstrong,, P. A. Hossler,, C. H. Lee,, L. Huang,, C. B. Beard,, J. Carter,, L. Crane,, J. Duchin,, W. Burman,, J. Richardson, and, S. R. Meshnick. 2001. Pneumocystis carinii cytochrome b mutations are associated with atovaquone exposure in patients with AIDS. J. Infect. Dis. 183: 819822.
54. Kazanjian, P. H.,, D. Fisk,, W. Armstrong,, Q. Shulin,, H. Liwei,, Z. Ke, and, S. Meshnick. 2004. Increase in prevalence of Pneumocystis carinii mutations in patients with AIDS and P. carinii pneumonia, in the United States and China. J. Infect. Dis. 189: 16841687.
55. Keely, S. P.,, J. M. Fischer,, M. T. Cushion, and, J. R. Stringer. 2004. Phylogenetic identification of Pneumocystis murina sp. nov., a new species in laboratory mice. Microbiology 150: 11531165.
56. Keely, S. P.,, H. Renauld,, A. E. Wakefield,, M. T. Cushion,, A. G. Smulian,, N. Fosker,, A. Fraser,, D. Harris,, L. Murphy,, C. Price,, M. A. Quail,, K. Seeger,, S. Sharp,, C. J. Tindal,, T. Warren,, E. Zuiderwijk,, B. G. Barrell,, J. R. Stringer, and, N. Hall. 2005. Gene arrays at Pneumocystis carinii telomeres. Genetics 170: 15891600.
57. Kessl, J. J.,, P. Hill,, B. B. Lange,, S. R. Meshnick,, B. Meunier, and, B. L. Trumpower. 2004. Molecular basis for atovaquone resistance in Pneumocystis jirovecii modeled in the cytochrome bc 1 complex of Saccharomyces cerevisiae. J. Biol. Chem. 279: 28172824.
58. Kovacs, J. A.,, J. W. Hiemenz,, A. M. Macher,, D. Stover,, H. W. Murray,, J. Shelhamer,, H. C. Lane,, C. Urmacher,, C. Honig, and, D. L. Longo. 1984. Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann. Intern. Med. 100: 663671.
59. Koziel, H.,, Q. Eichbaum,, B. A. Kruskal,, P. Pinkston,, R. A. Rogers,, M. Y. Armstrong,, F. F. Richards,, R. M. Rose, and, R. A. Ezekowitz. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J. Clin. Investig. 102: 13321344.
60. Koziel, H.,, S. Kim,, C. Reardon,, X. Li,, R. Garland,, P. Pinkston, and, H. Kornfeld. 1999. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 160: 20482055.
61. Kulke, M. H., and, E. A. Vance. 1997. Pneumocystis carinii pneumonia in patients receiving chemotherapy for breast cancer. Clin. Infect. Dis. 25: 215218.
62. Kutty, G., and, J. A. Kovacs. 2003. A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jirovecii. Infect. Immun. 71: 571574.
63. Lane, H. C.,, B. E. Laughon,, J. Falloon,, J. A. Kovacs,, R. T. J. Davey,, M. A. Polis, and, H. Masur. 1994. NIH conference. Recent advances in the management of AIDS-related opportunistic infections. Ann. Intern. Med. 120: 945955.
64. Laursen, A. L.,, J. Rungby, and, P. L. Andersen. 1995. Decreased activation of the respiratory burst in neutrophils from AIDS patients with previous Pneumocystis carinii pneumonia. J. Infect. Dis. 172: 497505.
65. Lee, L. H.,, F. Gigliotti,, T. W. Wright,, P. J. Simpson-Haidaris,, G. A. Weinberg, and, C. G. Haidaris. 2000. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242: 141150.
66. Li, P. G.,, D. Fenoglio,, L. Bottone,, P. Terranova,, E. Pontali,, F. Caroli,, M. Seri,, J. C. Cailliez,, G. Koopman,, R. Accolla,, F. del Galdo,, G. Abbate,, R. de Palma, and, F. Manca. 2002. Preservation of clonal heterogeneity of the Pneumocystis carinii-specific CD4 T cell repertoire in HIV infected, asymptomatic individuals. Clin. Exp. Immunol. 128: 155162.
67. Limper, A. H.,, J. E. Standing,, O. A. Hoffman,, M. Castro, and, L. W. Neese. 1993. Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect. Immun. 61: 43024309.
68. Lipschik, G. Y.,, J. F. Treml,, S. D. Moore, and, M. F. Beers. 1998. Pneumocystis carinii glycoprotein A inhibits surfactant phospholipid secretion by rat alveolar type II cells. J. Infect. Dis. 177: 182187.
69. Lobetti, R. 2000. Common variable immunodeficiency in miniature dachshunds affected with Pneumonocystis carinii pneumonia. J. Vet. Diagn. Investig. 12: 3945.
70. Ma, L.,, L. Borio,, H. Masur, and, J. A. Kovacs. 1999. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use. J. Infect. Dis. 180: 19691978.
71. Ma, L.,, G. Kutty,, Q. Jia, and, J. A. Kovacs. 2003. Characterization of variants of the gene encoding the p55 antigen in Pneumocystis from rats and mice. J. Med. Microbiol. 52: 955960.
72. Marcotte, H.,, D. Levesque,, K. Delanay,, A. Bourgeault,, R. de la Durantaye,, S. Brochu, and, M. C. Lavoie. 1996. Pneumocystis carinii infection in transgenic B cell-deficient mice. J. Infect. Dis. 173: 10341037.
73. Maskell, N. A.,, D. J. Waine,, A. Lindley,, J. C. Pepperell,, A. E. Wakefield,, R. F. Miller, and, R. J. Davies. 2003. Asymptomatic carriage of Pneumocystis jirovecii in subjects undergoing bronchoscopy: a prospective study. Thorax 58: 594597.
74. McAllister, F.,, C. Steele,, M. Zheng,, E. Young,, J. E. Shellito,, L. Marrero, and, J. K. Kolls. 2004. T cytotoxic-1 CD8 + T cells are effector cells against pneumocystis in mice. J. Immunol. 172: 11321138.
75. McCormack, F. X.,, A. L. Festa,, R. P. Andrews,, M. Linke, and, P. D. Walzer. 1997. The carbohydrate recognition domain of surfactant protein A mediates binding to the major surface glycoprotein of Pneumocystis carinii. Biochemistry 36: 80928099.
76. Mei, Q.,, R. E. Turner,, V. Sorial,, D. Klivington,, C. W. Angus, and, J. A. Kovacs. 1998. Characterization of major surface glycoprotein genes of human Pneumocystis carinii and high-level expression of a conserved region. Infect. Immun. 66: 42684273.
77. Meneau, I.,, D. Sanglard,, J. Bille, and, P. M. Hauser. 2004. Pneumocystis jirovecii dihydropteroate synthase polymorphisms confer resistance to sulfadoxine and sulfanilamide in Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 48: 26102616.
78. Montes-Cano, M. A.,, C. de la Horra,, J. Martin-Juan,, J. M. Varela,, R. Torronteras,, N. Respaldiza,, F. J. Medrano, and, E. J. Calderon. 2004. Pneumocystis jirovecii genotypes in the Spanish population. Clin. Infect. Dis. 39: 123128.
79. Morris, A.,, F. C. Sciurba,, I. P. Lebedeva,, A. Githaiga,, W. M. Elliott,, J. C. Hogg,, L. Huang, and, K. A. Norris. 2004. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am. J. Respir. Crit. Care Med. 170: 408413.
80. Nahimana, A.,, M. Rabodonirina,, J. Bille,, P. Francioli, and, P. M. Hauser. 2004. Mutations of Pneumocystis jirovecii dihydrofolate reductase associated with failure of prophylaxis. Antimicrob. Agents Chemother. 48: 43014305.
81. Pottratz, S. T.,, J. Paulsrud,, J. S. Smith, and, W. J. Martin. 1991. Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp120, a fibronectin binding protein. J. Clin. Investig. 88: 403407.
82. Qureshi, M. H.,, A. G. Harmsen, and, B. A. Garvy. 2003. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J. Immunol. 170: 10021009.
83. Rabeneck, L.,, T. Menke,, M. S. Simberkoff, et al. 2001. Using the national registry of HIV-infected veterans in research: lessons for the development of disease registries. J. Clin. Epidemiol. 54: 11951203.
84. Rice, W. R.,, F. M. Singleton,, M. J. Linke, and, P. D. Walzer. 1993. Regulation of surfactant phosphatidylcholine secretion from alveolar type II cells during Pneumocystis carinii pneumonia in the rat. J. Clin. Investig. 92: 27782782.
85. Richards, P. J.,, L. Riddell,, R. H. Reznek,, P. Armstrong,, A. J. Pinching, and, J. M. Parkin. 1996. High resolution computed tomography in HIV patients with suspected Pneumocystis carinii pneumonia and a normal chest radiograph. Clin. Radiol. 51: 689693.
86. Roths, J. B., and, C. L. Sidman. 1992. Both immunity and hyperresponsiveness to Pneumocystis carinii result from transfer of CD4 + but not CD8 + T cells into severe combined immunodeficiency mice. J. Clin. Investig. 90: 673678.
87. Roths, J. B., and, C. L. Sidman. 1993. Single and combined humoral and cell-mediated immunotherapy of Pneumocystis carinii pneumonia in immunodeficient scid mice. Infect. Immun. 61: 16411649.
88. Rudmann, D. G.,, A. M. Preston,, M. W. Moore, and, J. M. Beck. 1998. Susceptibility to Pneumocystis carinii in mice is dependent on simultaneous deletion of IFN-gamma and type 1 and 2 TNF receptor genes. J. Immunol. 161: 360366.
89. Shellito, J.,, V. V. Suzara,, W. Blumenfeld,, J. M. Beck,, H. J. Steger, and, T. H. Ermak. 1990. A new model of Pneumocystis carinii infection in mice selectively depleted of helper T lymphocytes. J. Clin. Invest. 85: 16861693.
90. Shellito, J. E.,, J. K. Kolls,, R. Olariu, and, J. M. Beck. 1996. Nitric oxide and host defense against Pneumocystis carinii infection in a mouse model. J. Infect. Dis. 173: 432439.
91. Smulian, A. G.,, J. R. Stringer,, M. J. Linke, and, P. D. Walzer. 1992. Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect. Immun. 60: 907915.
92. Smulian, A. G.,, D. W. Sullivan,, M. J. Linke,, N. A. Halsey,, T. C. Quinn,, A. P. MacPhail,, M. A. Hernandez-Avila,, S. T. Hong, and, P. D. Walzer. 1993. Geographic variation in the humoral response to Pneumocystis carinii. J. Infect. Dis. 167: 12431247.
93. Smulian, A. G., and, S. A. Theus. 1994. Cellular immune response in Pneumocystis carinii infection. Parasitol. Today 10: 229231.
94. Smulian, A. G., and, P. D. Walzer. 1994. Serological studies of Pneumocystis carinii infection, p. 141154. In P. D. Walzer (ed.), Pneumocystis carinii Pneumonia. Marcel Dekker, Inc., New York, N.Y.
95. Society of Protozoologists. 1994. Revised nomenclature for Pneumocystis carinii. The Pneumocystis workshop. J. Eukaryot. Microbiol. 41: 121s122s.
96. Steele, C.,, L. Marrero,, S. Swain,, A. G. Harmsen,, M. Zheng,, G. D. Brown,, S. Gordon,, J. E. Shellito, and, J. K. Kolls. 2003. Alveolar macrophage-mediated killing of Pneumocystis carinii f. sp. muris involves molecular recognition by the Dectin-1 beta-glucan receptor. J. Exp. Med. 198: 16771688.
97. Steele, C.,, M. Zheng,, E. Young,, L. Marrero,, J. E. Shellito, and, J. K. Kolls. 2002. Increased host resistance against Pneumocystis carinii pneumonia in γδ T-cell-deficient mice: protective role of gamma interferon and CD8 + T cells. Infect. Immun. 70: 52085215.
98. Stehle, S. E.,, R. A. Rogers,, A. G. Harmsen, and, R. A. Ezekowitz. 2000. A soluble mannose receptor immunoadhesin enhances phagocytosis of Pneumocystis carinii by human polymorphonuclear leukocytes in vitro. Scand. J. Immunol. 52: 131137.
99. Stein, C. R.,, C. Poole,, P. Kazanjian, and, S. R. Meshnick. 2004. Sulfa use, dihydropteroate synthase mutations, and Pneumocystis jirovecii pneumonia. Emerg. Infect. Dis. 10: 17601765.
100. Stringer, J. R., and, S. P. Keely. 2001. Genetics of surface antigen expression in Pneumocystis carinii. Infect. Immun. 69: 627639.
101. Stringer, S. L.,, J. R. Stringer,, M. A. Blase,, P. D. Walzer, and, M. T. Cushion. 1989. Pneumocystis carinii : sequence from ribosomal RNA implies a close relationship with fungi. Exp. Parasitol. 68: 450461.
102. Su, T. H.,, V. Natarajan,, D. L. Kachel,, M. A. Moxley,, W. J. Longmore, and, W. J. Martin. 1996. Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J. Lab. Clin. Med. 127: 263271.
103. Takahashi, T.,, T. Endo,, T. Nakamura,, H. Sakashitat,, K. Kimurat,, K. Ohnishit,, Y. Kitamura, and, A. Iwamoto. 2002. Dihydrofolate reductase gene polymorphisms in Pneumocystis carinii f. sp. hominis in Japan. J. Med. Microbiol. 51: 510515.
104. Theus, S. A.,, R. P. Andrews,, P. Steele, and, P. D. Walzer. 1995. Adoptive transfer of lymphocytes sensitized to the major surface glycoprotein of Pneumocystis carinii confers protection in the rat. J. Clin. Investig. 95: 25872593.
105. Theus, S. A.,, N. Sawhney,, A. G. Smulian, and, P. D. Walzer. 1998. Proliferative and cytokine responses of human T lymphocytes isolated from human immunodeficiency virus-infected patients to the major surface glycoprotein of Pneumocystis carinii. J. Infect. Dis. 177: 238241.
106. Theus, S. A.,, A. G. Smulian,, P. Steele,, M. J. Linke, and, P. D. Walzer. 1998. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 16: 11491157.
107. Theus, S. A.,, D. W. Sullivan,, P. D. Walzer, and, A. G. Smulian. 1994. Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect. Immun. 62: 34793484.
108. Thomas, C. F., Jr., and, A. H. Limper. 2004. Pneumocystis pneumonia. N. Engl. J. Med. 350: 24872498.
109. Vargas, S. L.,, W. T. Hughes,, M. E. Santolaya,, A. V. Ulloa,, C. A. Ponce,, C. E. Cabrera,, F. Cumsille, and, F. Gigliotti. 2001. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin. Infect. Dis. 32: 855861.
110. Vargas, S. L.,, C. A. Ponce,, W. T. Hughes,, A. E. Wakefield,, J. C. Weitz,, S. Donoso,, A. V. Ulloa,, P. Madrid,, S. Gould,, J. J. Latorre,, R. Avila,, S. Benveniste,, M. Gallo,, J. Belletti, and, R. Lopez. 1999. Association of primary Pneumocystis carinii infection and sudden infant death syndrome. Clin. Infect. Dis. 29: 14891493.
111. Vargas, S. L.,, C. A. Ponce,, C. A. Sanchez,, A. V. Ulloa,, R. Bustamante, and, G. Juarez. 2003. Pregnancy and asymptomatic carriage of Pneumocystis jirovecii. Emerg. Infect. Dis. 9: 605606.
112. Vassallo, R.,, T. J. Kottom,, J. E. Standing, and, A. H. Limper. 2001. Vitronectin and fibronectin function as glucan binding proteins augmenting macrophage responses to Pneumocystis carinii. Am. J. Respir. Cell Mol. Biol. 25: 203211.
113. Vassallo, R.,, C. F. Thomas, Jr.,, Z. Vuk-Pavlovic, and, A. H. Limper. 2000. Mechanisms of defence in the lung: lessons from Pneumocystis carinii pneumonia. Sarcoidosis Vasc. Diffuse Lung Dis. 17: 130139.
114. Walker, D. J.,, A. E. Wakefield,, M. N. Dohn,, R. F. Miller,, R. P. Baughman,, P. A. Hossler,, M. S. Bartlett,, J. W. Smith,, P. Kazanjian, and, S. R. Meshnick. 1998. Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure. J. Infect. Dis. 178: 17671775.
115. Walzer, P. D. 2004. Immunological features of Pneumocystis infection in humans, p. 451477. In M. T. Cushion and, P. D. Walzer (ed.), Pneumocystis Pneumonia. Marcel Dekker, Inc., New York, N.Y.
116. Walzer, P. D.,, C. K. Kim, and, M. T. Cushion. 1989. Pneumocystis carinii, p. 83178. In P. D. Walzer and, R. M. Genta (ed.), Parasitic Infections in the Immunocompromised Host. Marcel Dekker, Inc., New York, N.Y.
117. Walzer, P. D.,, C. K. Kim,, M. J. Linke,, C. L. Pogue,, M. J. Huerkamp,, C. E. Chrisp,, A. V. Lerro,, S. K. Wixson,, E. Hall, and, L. D. Shultz. 1989. Outbreaks of Pneumocystis carinii pneumonia in colonies of immunodeficient mice. Infect. Immun. 57: 6270.
118. Warschkau, H.,, H. Yu, and, A. F. Kiderlen. 1998. Activation and suppression of natural cellular immune functions by Pneumocystis carinii. Immunobiology 198: 343360.
119. Wiley, J. A., and, A. G. Harmsen. 1995. CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice. J. Immunol. 155: 35253529.
120. Wright, T. W.,, C. J. Johnston,, A. G. Harmsen, and, J. N. Finkelstein. 1999. Chemokine gene expression during Pneumocystis carinii-driven pulmonary inflammation. Infect. Immun. 67: 34523460.
121. Wright, T. W.,, R. H. Notter,, Z. Wang,, A. G. Harmsen, and, F. Gigliotti. 2001. Pulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia. Infect. Immun. 69: 758764.
122. Wu, A. K.,, V. C. Cheng,, B. S. Tang,, I. F. Hung,, R. A. Lee,, D. S. Hui, and, K. Y. Yuen. 2004. The unmasking of Pneumocystis jirovecii pneumonia during reversal of immunosuppression: case reports and literature review. BMC Infect. Dis. 4: 57.
123. Zheng, M.,, J. E. Shellito,, L. Marrero,, Q. Zhong,, S. Julian,, P. Ye,, V. Wallace,, P. Schwarzenberger, and, J. K. Kolls. 2001. CD4 + T cell-independent vaccination against Pneumocystis carinii in mice. J. Clin. Investig. 108: 14691474.


Generic image for table
Table 1.

Taxonomic hierarchy of

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25
Generic image for table
Table 2.

Underlying conditions leading to development of PCP

Citation: Smulian A, Cushion M. 2006. Pathogenesis of , p 347-361. In Heitman J, Filler S, Edwards, Jr. J, Mitchell A (ed), Molecular Principles of Fungal Pathogenesis. ASM Press, Washington, DC. doi: 10.1128/9781555815776.ch25

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error